We demonstrated that Oct4 was highly expressed in breast cancers with aggressive features such as high histologic grade high Ki-67 proliferation index and HER2 amplification, and the non-luminal A molecular subtypes. The gene discussed is ERBB2; the disease is breast carcinoma.